checkAd
    Startseite > Aktien > Immutep > Nachrichten
    Immutep
    Aktie
    ISIN: US45257L1089 WKN: A2H8YL SYM: YP1A Land Australien
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    2,5400
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 14.06.24 Tradegate
    Geldkurs
    16:08:55
    2,5200
     
    EUR
    1.200 STK
    Briefkurs
    16:08:55
    2,5600
     
    EUR
    1.200 STK

    Immutep Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 06.06.2024
    06.06.24 · wO Chartvergleich · DMG MORI
    Immutep successfully completes institutional placement and institutional component of entitlement offer
    05.06.24 · globenewswire · Immutep
    Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA (pembrolizumab) in Pivotal Phase III Trial
    03.06.24 · globenewswire · Immutep
    Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024
    15.05.24 · globenewswire · Immutep
    Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
    02.05.24 · globenewswire · Immutep
    Immutep Quarterly Activities Report Q3 FY24
    29.04.24 · globenewswire · Immutep
    Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
    24.04.24 · globenewswire · Immutep
    Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
    18.04.24 · globenewswire · Immutep
    Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
    17.04.24 · globenewswire · Immutep
    Immutep Announces First Clinical Data from 90mg Dosing of Efti
    05.03.24 · globenewswire · Immutep
    Immutep Quarterly Activities Report Q2 FY24
    30.01.24 · globenewswire · Immutep
    First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO in Metastatic Urothelial Cancer
    04.01.24 · globenewswire · Immutep